Nanoengineering has emerged as a groundbreaking discipline within the pharmaceutical field, revolutionizing drug delivery and therapeutic interventions. At the intersection of nanotechnology and pharmaceuticals, nanoengineering involves the design, manipulation, and application of materials at the nanoscale to enhance drug efficacy and minimize adverse effects. By exploiting the unique properties exhibited by materials at the nanoscale, such as increased surface area and improved bioavailability, nanoengineering enables precise control over drug release kinetics and targeted delivery to specific cells or tissues.
This approach holds tremendous promise for addressing challenges associated with traditional drug formulations, including poor solubility and systemic toxicity. Nanoengineered pharmaceuticals, often in the form of nanoparticles or liposomes, can traverse biological barriers more effectively, allowing for enhanced therapeutic outcomes. Moreover, the ability to incorporate imaging agents into these nanostructures facilitates real-time monitoring of drug distribution within the body. As nanoengineering continues to evolve, it offers unparalleled opportunities to optimize drug design, improve patient compliance, and usher in a new era of personalized medicine in the pharmaceutical landscape.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India